
Summaries like this, in your inbox every morning.
Sign up free →Amazon Pharmacy launched Eli Lilly's GLP-1 weight loss medication with same-day delivery capability, directly challenging Hims & Hers' market position
Hims & Hers is developing an AI-powered product approach to support new non-prescription solutions and drive product launches later in 2024
Hims & Hers faces dual pressure from increased competition and regulatory scrutiny as weight loss medications become a larger portion of its business
The competitive landscape is shifting as major retailers like Amazon leverage their logistics infrastructure to enter the telehealth weight loss market
No discussion yet for this article
Get curated AI news from 200+ sources delivered daily to your inbox. Free to use.
Get Started FreeFree · takes 30 seconds · unsubscribe anytime
1 minute a day. The AI essentials.
200+ sources · Email / LINE / Slack